Tamarind (Tamarindus indica L.) seed a candidate protein source with potential for combating SARS-CoV-2 infection in obesity

dc.contributor.authorMorais, Ana Heloneida de Araújo
dc.contributor.authorMedeiros, Amanda F. de
dc.contributor.authorMedeiros, Isaiane
dc.contributor.authorLima, Vanessa C. O. de
dc.contributor.authorLuz, Anna B. S.
dc.contributor.authorMaciel, Bruna L. L.
dc.contributor.authorPassos, Thaís S.
dc.contributor.authorIDhttps://orcid.org/0000-0002-6460-911Xpt_BR
dc.date.accessioned2023-08-01T18:26:56Z
dc.date.available2023-08-01T18:26:56Z
dc.date.issued2021
dc.description.resumoIntroduction: Obesity and coronavirus disease (COVID)-19 are overlapping pandemics, and one might worsen the other. Methods: This narrative review discusses one of the primary mechanisms to initiate acute respiratory distress syndrome, uncontrolled systemic inflammation in COVID-19, and presents a potential candidate for adjuvant treatment. Blocking the S protein binding to angiotensin-converting enzyme 2 (ACE-2) and the 3C-like protease (3CL pro) is an effective strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Results: Host proteases such as FURIN, trypsin, and transmembrane serine protease 2 (TMPRSS) act in S protein activation. Tamarind trypsin inhibitor (TTI) shows several beneficial effects on the reduction of inflammatory markers (tumor necrosis factor α [TNF-α], leptin) and biochemical parameters (fasting glycemia, triglycerides, and very low-density lipoprotein [VLDL]), in addition to improving pancreatic function and mucosal integrity in an obesity model. TTI may inhibit the action of proteases that collaborate with SARS-CoV-2 infection and the neutro phil activity characteristic of lung injury promoted by the virus. Conclusion: Thus, TTI may contribute to combating two severe overlapping problems with high cost and social complex implications, obesity and COVID-19.pt_BR
dc.identifier.citationMORAIS, A. H. A.; MEDEIROS, A. F. ; MEDEIROS, I. ; LIMA, V. C. O. ; LUZ, A. B. S. ; Maciel B L L ; PASSOS, T. S. Tamarind (Tamarindus indica L.) seed a candidate protein source with Potential for combating SARS-CoV-2 infection in obesity. Drug Target Insights, v. 15, p. 5-12, 2021.pt_BR
dc.identifier.doi10.33393/dti.2021.2192
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/54326
dc.languageenpt_BR
dc.publisherDrug Target Insightspt_BR
dc.rightsAttribution-NonCommercial 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/br/*
dc.subject3CLpropt_BR
dc.subjectACE-2pt_BR
dc.subjectCOVID-19pt_BR
dc.subjectFURINpt_BR
dc.subjectHNEpt_BR
dc.subjectInflammationpt_BR
dc.subjectTMPRSSpt_BR
dc.titleTamarind (Tamarindus indica L.) seed a candidate protein source with potential for combating SARS-CoV-2 infection in obesitypt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
Tamarind (Tamarindus indica L.)_Morais_2021.pdf
Tamanho:
490.28 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar